It has been 20 years since the U.S. direct-to-consumer advertising regulations were loosed. Prior to the change in regulations, pharmaceutical marketing to consumers was only $700 million. In 2016, over 10 billion dollars was spent on consumer advertising by pharmaceutical companies. In an effort to educate patients and encourage them to speak to their healthcare providers, it has become industry standard for device manufactures (knees, hips, spine, heart, etc.) and insurance companies to market directly to patients. Billions of dollars are spent annually on media, radio and print in an effort to build brand recognition with patients.
eMarketMD is changing the way pharmaceutical companies, device manufacturers and insurance companies market their products and solutions to consumers. Our technology and strategic partnerships enable these industries to invest their marketing dollars in technology that delivers results targeted to a specific market.